Viscosity regulates cell spreading and cell-extracellular matrix interactions.
Abstract
Fluid viscosity and osmolarity are among some of the underappreciated mechanical stimuli that cells can detect. Abnormal changes of multiple fluidic factors such as viscosity and osmolarity have been linked with diseases such as cystic fibrosis, cancer, and coronary heart disease. Changes in viscosity have been recently suggested as a regulator of cell locomotion. These novel studies focus on cell migration and spreading on glass substrates and through microchannels, and it remains a question whether viscosity impacts the cellular remodeling of extracellular matrices (ECMs). Here, we demonstrate that elevated viscosity induces cellular remodeling of collagen substrates and enhances cell spreading on ECM-mimetic substrates. Our results expand on recent work showing that viscosity induces increased cellular forces and demonstrates that viscosity can drive local ECM densification. Our data further show that microtubules, Ras-related C3 botulinum toxin substrate 1 (Rac1), actin-related protein 2/3 (Arp2/3) complex, Rho-associated protein kinase 1 (ROCK), and myosin are important regulators of viscosity-induced ECM remodeling. In the context of viscosity-induced cell spreading, cells cultured on glass and collagen substrates exhibit markedly different responses to pharmacological treatments, indicating that microtubules, Rac1, and Arp2/3 play distinct roles in regulating cellular spreading depending on the substrate. In addition, our results demonstrate that high osmotic pressures override viscosity-induced cell spreading by suppressing membrane ruffling. Our results demonstrate viscosity as a regulator of ECM remodeling and cell spreading in a fibrillar microenvironment. We also reveal a complex interplay between viscosity and osmolarity. We anticipate that our research can pave the way for future investigations into the crucial roles played by viscosity in both physiological and pathological conditions.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | cell-extracellular matrix
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | cellular
|
scispacy | 1 | ||
| 해부 | extracellular
|
scispacy | 1 | ||
| 해부 | ECMs
→ extracellular matrices
|
scispacy | 1 | ||
| 해부 | ECM
|
scispacy | 1 | ||
| 해부 | microtubules
|
scispacy | 1 | ||
| 해부 | membrane
|
scispacy | 1 | ||
| 해부 | fibrillar
|
scispacy | 1 | ||
| 합병증 | cystic
|
scispacy | 1 | ||
| 약물 | Arp2/3
→ actin-related protein 2/3
|
C0676792
Actin-Related Protein 2
|
scispacy | 1 | |
| 약물 | Fluid
|
scispacy | 1 | ||
| 질환 | fibrosis
|
C0016059
Fibrosis
|
scispacy | 1 | |
| 질환 | cancer
|
C0006826
Malignant Neoplasms
|
scispacy | 1 | |
| 질환 | coronary heart disease
|
C0010054
Coronary Arteriosclerosis
|
scispacy | 1 | |
| 질환 | Arp2/3
→ actin-related protein 2/3
|
C0676792
Actin-Related Protein 2
|
scispacy | 1 | |
| 질환 | myosin
|
C0027096
Myosin ATPase
|
scispacy | 1 | |
| 기타 | coronary heart
|
scispacy | 1 | ||
| 기타 | collagen
|
scispacy | 1 | ||
| 기타 | Ras-related C3 botulinum toxin substrate 1
|
scispacy | 1 | ||
| 기타 | Rac1
→ Ras-related C3 botulinum toxin substrate 1
|
scispacy | 1 | ||
| 기타 | actin-related protein 2/3
|
scispacy | 1 | ||
| 기타 | Arp2/3
→ actin-related protein 2/3
|
scispacy | 1 | ||
| 기타 | ROCK
→ Rho-associated protein kinase 1
|
scispacy | 1 |
MeSH Terms
Extracellular Matrix; Viscosity; Cell Movement; rac1 GTP-Binding Protein; Humans; rho-Associated Kinases; Microtubules; Collagen; Animals; Myosins
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.